28 results
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm
(Revised Edition 2020) (the “ESA”)
The above legislation is aimed at addressing concerns raised by the Council of the European Union as to offshore
F-1
PRTG
Portage Biotech Inc
31 Oct 23
Registration statement (foreign)
4:05pm
legislation is aimed at addressing concerns raised by the Council of the European Union as to offshore structures engaged in certain activities, which attract
6-K
EX-10.1
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
”)
The above legislation is aimed at addressing concerns raised by the Council of the European Union as to offshore structures engaged in certain … of the European Union and the currency that is used in certain of its member states; and
"shares" or "ordinary shares" refers to the authorized ordinary
424B5
zpmpz3pe3 ztk9xa
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-10.3
tplffs2rn3q
8 Jul 22
Current report (foreign)
8:58am
SUPPL
4b23tp
24 Jun 21
Supplemental materials (foreign)
5:27pm
6-K
EX-1.1
vqzjzk
24 Jun 21
Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
4:05pm
SUPPL
m1brcg
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
08kx2 0zmjt
8 Mar 21
Prospectus for primary offering
5:00pm
F-3
4aq98vsh
24 Feb 21
Shelf registration (foreign)
5:22pm
F-3
EX-1.1
fkeanah9nuog578xa
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
5zgn1h8wf 3i
19 Feb 19
Report of Foreign Private Issuer
10:37am